Boston CEO Conference to Feature CEOs of Alkermes plc, Alnylam Pharmaceuticals, Ariad Pharmaceuticals, Inc., Biogen Idec, Inc. (Massachusetts), Cubist Pharmaceuticals, Inc., Genzyme Corporation, Millennium, Momenta Pharmaceuticals, Inc., Sirtris Pharmaceu
Published: May 24, 2012
BOSTON--(BUSINESS WIRE)--More than 200 leading CEOs will gather at the 2012 CEO Conference June 11th and 12th at the Mandarin Oriental Hotel in Boston. The Boston CEO Conference is a forum for industry CEOs and decision makers in the life sciences. Attendees gain insights from presentations and panels featuring CEOs from several of the world's leading biopharmaceutical companies. Industry leaders in venture capital, strategic consulting and private equity also participate.